Jefferies Group LLC Boston Scientific Corp Transaction History

Jefferies Group LLC

$10.2 Billion
Q3 2022

A detailed history of Jefferies Group LLC transactions in Boston Scientific Corp stock. As of the latest transaction made, Jefferies Group LLC holds 47,911 shares of BSX stock, worth $4.17 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

47,911

Previous 52,909 9.45%

Holding current value

$4.17 Million

Previous $1.97 Million 5.89%

% of portfolio

0.02%

Previous 0.02%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Sep 21, 2023	SELL	$36.71 - $109.66 $183,476 - $548,080	-4,998 Reduced 9.45%	47,911 $1.86 Million
Q3 2022 Nov 14, 2022	SELL	$36.71 - $109.66 $183,476 - $548,080	-4,998 Reduced 9.45%	47,911 $1.86 Million
Q2 2022 Sep 21, 2023	SELL	$35.24 - $47.1 $21,672 - $28,966	-615 Reduced 1.15%	52,909 $1.97 Million
Q2 2022 Aug 15, 2022	SELL	$35.24 - $47.1 $21,672 - $28,966	-615 Reduced 1.15%	52,909 $1.97 Million
Q1 2022 Sep 21, 2023	BUY	$40.9 - $45.1 $777,468 - $857,305	19,009 Added 55.07%	53,524 $2.37 Million
Q1 2022 May 16, 2022	BUY	$40.9 - $45.1 $777,468 - $857,305	19,009 Added 55.07%	53,524 $2.37 Million
Q4 2021 Sep 21, 2023	SELL	$38.07 - $44.87 $842,070 - $992,479	-22,119 Reduced 39.06%	34,515 $1.47 Million
Q4 2021 Feb 14, 2022	SELL	$38.07 - $44.87 $842,070 - $992,479	-22,119 Reduced 39.06%	34,515 $1.47 Million
Q3 2021 Sep 21, 2023	SELL	$41.23 - $45.88 $1.39 Million - $1.54 Million	-33,666 Reduced 37.28%	56,634 $2.46 Million
Q3 2021 Nov 15, 2021	SELL	$41.23 - $45.88 $1.39 Million - $1.54 Million	-33,666 Reduced 37.28%	56,634 $2.46 Million
Q2 2021 Sep 21, 2023	BUY	$38.58 - $44.24 $53,471 - $61,316	1,386 Added 1.56%	90,300 $3.86 Million
Q2 2021 Aug 16, 2021	BUY	$38.58 - $44.24 $53,471 - $61,316	1,386 Added 1.56%	90,300 $3.86 Million
Q1 2021 Sep 21, 2023	BUY	$35.27 - $39.67 $2.43 Million - $2.73 Million	68,909 Added 344.46%	88,914 $3.44 Million
Q1 2021 May 14, 2021	BUY	$35.27 - $39.67 $2.43 Million - $2.73 Million	68,909 Added 344.46%	88,914 $3.44 Million
Q4 2020 Sep 21, 2023	SELL	$33.15 - $41.97 $925,083 - $1.17 Million	-27,906 Reduced 58.25%	20,005 $719,000
Q4 2020 Feb 16, 2021	SELL	$33.15 - $41.97 $4.79 Million - $6.06 Million	-144,351 Reduced 87.83%	20,005 $719,000
Q3 2020 Nov 13, 2020	BUY	$34.44 - $42.23 $4.65 Million - $5.7 Million	134,990 Added 459.68%	164,356 $6.28 Million
Q2 2020 Aug 14, 2020	BUY	$30.19 - $39.11 $2,445 - $3,167	81 Added 0.28%	29,366 $1.03 Million
Q1 2020 May 15, 2020	SELL	$25.83 - $45.71 $1.5 Million - $2.66 Million	-58,100 Reduced 66.49%	29,285 $956,000
Q4 2019 Feb 13, 2020	BUY	$37.87 - $45.37 $1.91 Million - $2.29 Million	50,454 Added 136.62%	87,385 $3.95 Million
Q3 2019 Nov 13, 2019	SELL	$40.31 - $43.45 $621,136 - $669,521	-15,409 Reduced 29.44%	36,931 $1.5 Million
Q2 2019 Aug 14, 2019	SELL	$34.91 - $42.98 $1.43 Million - $1.76 Million	-41,010 Reduced 43.93%	52,340 $2.25 Million
Q1 2019 May 15, 2019	BUY	$32.91 - $40.75 $1.52 Million - $1.88 Million	46,213 Added 98.04%	93,350 $3.58 Million
Q4 2018 Feb 14, 2019	BUY	$31.73 - $39.04 $442,189 - $544,061	13,936 Added 41.97%	47,137 $1.67 Million
Q3 2018 Nov 14, 2018	SELL	$32.83 - $38.63 $1.07 Million - $1.26 Million	-32,677 Reduced 49.6%	33,201 $1.28 Million
Q2 2018 Aug 14, 2018	BUY	$26.84 - $34.32 $1.54 Million - $1.97 Million	57,525 Added 688.67%	65,878 $2.15 Million
Q1 2018 May 15, 2018	SELL	$25.2 - $28.54 $6.48 Million - $7.34 Million	-257,334 Reduced 96.86%	8,353 $228,000
Q4 2017 Feb 14, 2018	BUY	$24.79 - $29.8 $6.43 Million - $7.73 Million	259,287 Added 4051.36%	265,687 $6.59 Million
Q3 2017 Nov 14, 2017	BUY	$26.26 - $29.17 $168,064 - $186,688	6,400	6,400 $187,000

Others Institutions Holding BSX

# of Institutions

1,537

Shares Held

1.19B

Call Options Held

6.79M

Put Options Held

10.1M

View Full List

About BOSTON SCIENTIFIC CORP

Ticker BSX
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,431,609,984
Market Cap $125B
Description
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...

More about BSX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jefferies Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jefferies Group LLC with notifications on news.

Account

Jefferies Group LLC Boston Scientific Corp Transaction History